Dutch Melanoma Treatment Registry: Quality assurance in the care of patients with metastatic melanoma in the Netherlands
European Journal of Cancer2016Vol. 72, pp. 156–165
Citations Over TimeTop 10% of 2016 papers
Anouk Jochems, Maartje G. Schouwenburg, B Leeneman, M Franken, Alfons J.M. van den Eertwegh, John B.A.G. Haanen, Hans Gelderblom, Carin A. Uyl‐de Groot, Maureen J.B. Aarts, Franchette W.P.J. van den Berkmortel, Willeke A.M. Blokx, Mathilde C. Cardous-Ubbink, Gerard Groenewegen, Jan Willem B. de Groot, Geke A.P. Hospers, Ellen Kapiteijn, Rutger H.T. Koornstra, Wim H.J. Kruit, Marieke W.J. Louwman, Djura Piersma, Rozemarijn S. van Rijn, Albert J. ten Tije, Gerard Vreugdenhil, Michel W.J.M. Wouters, Jacobus J. M. van der Hoeven
Related Papers
- → Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 Levels(2014)57 cited
- → The Ipilimumab Lesson in Melanoma: Achieving Long-Term Survival(2015)28 cited
- → Ipilimumab in anti-PD1 refractory metastatic melanoma(2015)18 cited
- → Retrospective Analysis of Rechallenge with Ipilimumab in Patients with Metastatic Melanoma(2021)3 cited
- → Treatment Patterns among Advanced Melanoma Patients in Europe(2016)